Cargando…
192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
Autores principales: | Morrill, Haley, Caffrey, Aisling, Noh, Eunsun, Laplante, Kerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782279/ http://dx.doi.org/10.1093/ofid/ofu052.58 |
Ejemplares similares
-
721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014) -
313 Value of Discontinuation of Contact Precautions (CP) for Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Shenoy, Erica S., et al.
Publicado: (2014) -
272 Characteristics of USA500/Iberian Methicillin-Resistant Staphylococcus aureus (MRSA) Invasive Disease
por: Melendez, Andre G., et al.
Publicado: (2014) -
314 When Should Contact Precautions be Discontinued for Patients with Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Oh, Yumi, et al.
Publicado: (2014) -
1796 Recovery of Clostridium difficile, Vancomycin Resistant Enterococcus and Methicillin Resistant Staphylococcus aureus from the Food of Hospitalized Patients
por: Kwon, Jennie H., et al.
Publicado: (2014)